Health Care: Drugs

Proteostasis Therapeutics Inc (PTI: NASDAQ)

$10.88 0.38 | 3.62%
12/05/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 10.50
52 Week High 20.63
52 Week Low 5.27
Avg. Daily Vol. (Mil) 0.27
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 262.08
Shares Out (Mil) 24.96
Float (Mil) 5.50
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 8.50
Current Ratio 8.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 47.15
Price/Book 2.91
Price/Cash Flow -5.90
Per Share Data
Earnings -0.02
Sales 0.22
Book Value 3.60
Cash Flow -1.77
Business Summary
Proteostasis Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel therapeutics that treat diseases caused by an imbalance in the proteostasis network.
General Information
200 Technology Square
4th Floor
Cambridge, MA 02139
www.proteostasis.com
Industry : Drugs
Sector: Health Care
Employees: 41
CEO: Ms. Meenu Chhabra
Short Interest
Current Month (Mil) 0.55
Previous Month (Mil) 0.41
Short Interest Ratio (Days) 2.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -32.20
Return on Investments -37.20
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PTI

Latest PTI Headlines from TheStreet

More Financial News for PTI

Press Releases for PTI

See All Press Releases

Partner Headlines for PTI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter